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We report here the first direct assessment of 
the specificity of a class of peptidoglycan 
cross-linking enzymes, the L,D-
transpeptidases, for the highly diverse 
structure of peptidoglycan precursors of 
Gram-positive bacteria. The lone functionally 
characterized member of this new family of 
active site cystein peptidases, Ldtfm from 
Enterococcus faecium, was previously shown 
to by-pass the D,D-transpeptidase activity of 
the classical penicillin-binding proteins 
(PBPs) leading to high-level cross-resistance 
to glycopeptide and β-lactam antibiotics. 
Ldtfm homologues from Bacillus subtilis 
(LdtBs) and E. faecalis (Ldtfs) were found here 
to cross-link their cognate disaccharide-
peptide subunits containing meso-
diaminopimelic acid (mesoDAP3) and L-Lys3-
L-Ala-Ala at the third position of the stem 
peptide, respectively, instead of L-Lys3-D-iAsn 
in E. faecium. Ldtfs differed from Ldtfm and 
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LdtBs by its capacity to hydrolyze the L-Lys3-
D-Ala4 bond of tetrapeptide (L,D-
carboxypeptidase activity) and pentapeptide 
(L,D-endopeptidase activity) stems, in addition 
to the common cross-linking activity. The 
three enzymes were specific for their cognate 
acyl acceptors in the cross-linking reaction. In 
contrast to Ldtfs, which was also specific for 
its cognate acyl donor, Ldtfm tolerated 
substitution of L-Lys3-D-iAsn by L-Lys3-L-Ala-
L-Ala. Likewise, LdtBs tolerated substitution 
of mesoDAP3 by L-Lys3-D-iAsn and L-Lys3-L-
Ala-L-Ala in the acyl donor. Thus, 
diversification of the structure of 
peptidoglycan precursors associated with 
speciation has led to a parallel evolution of the 
substrate specificity of the L,D-
transpeptidases affecting mainly the 
recognition of the acyl acceptor. Blocking the 
assembly of the side chain could therefore be 
used to combat antibiotic resistance involving 
L,D-transpeptidases. 
 
The bacterial cell wall peptidoglycan is a net-like 
macromolecule which surrounds the cytoplasmic 
membrane (1). The polymer is essential since it 
supplies the cell with mechanical protection 
against the osmotic pressure of the cytoplasm. 
The peptidoglycan subunit contains β-1,4-linked 
N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc) substituted by a 
peptide stem (Fig. 1A) (2). Assembly of the 
subunit at the cell surface is performed by 
glycosyltransferases that polymerize the glycan 
strands by formation of β-1,4 bonds and D,D-
transpeptidases that cross-link glycan strands (2). 
The latter reaction is catalyzed by penicillin-
binding proteins (PBPs) that cleave the D-Ala4-
D-Ala5 bond of a donor stem pentapeptide and 
link the carbonyl of D-Ala4 to the amino group of 
the side chain carried by the third residue of an 
acceptor stem peptide (Fig. 1B). This two-step 
reaction involves formation of a covalent adduct 
between the β-hydroxyl of the active site serine 
of the PBPs and the carbonyl of D-Ala4 of the 
donor stem (3). The glycosyltransferase and D,D-
transpeptidase activities of the multimodular 
peptidoglycan polymerases are the targets of the 
two major classes of antibiotics available to treat 
severe infections due to Gram-positive bacteria, 
the β-lactams and the glycopeptides, that act by 
different mechanisms. The β-lactams are 
structural analogues of D-Ala4-D-Ala5 and act as 
suicide substrates of the D,D-transpeptidase 
module of the PBPs. The glycopeptides bind to 
the peptidyl-D-Ala4-D-Ala5 extremity of 
peptidoglycan precursors and block by steric 
hindrance both the transglycosylation and 
transpeptidation reactions (4). 
The assembly pathway of peptidoglycan 
precursors and its mode of polymerization are 
generally highly conserved in eubacteria. 
Variations in the structure of peptidoglycan 
subunits involve mainly the fifth (C-terminal) 
and third positions of the pentapeptide stem (5). 
The specificity of peptidoglycan cross-linking 
enzymes for the donor is the bottle neck that 
limits emergence of resistance to glycopeptides 
since the modifications of the precursors that 
prevent drug binding should be tolerated by 
these enzymes (4,6). Successful modifications 
which have spread in Gram-positive pathogens 
under the selective pressure of glycopeptides 
include incorporation of D-lactate or D-Ser 
instead of D-Ala at the 5th position of 
pentapeptide stems (7). Strikingly, production of 
D-lactate-ending precursors can also have an 
impact on the activity of β-lactams in the 
enterococci and staphylococci, presumably 
because low-affinity PBPs responsible for β-
lactam resistance cannot function with modified 
precursors (6,8). Total elimination of D-Ala5 by 
hydrolysis of the C-terminal residue of 
pentapeptide stems is an alternative mechanism 
of glycopeptide resistance in mutants of 
Enterococcus faecium selected in laboratory 
conditions (9). Since PBPs cannot function with 
tetrapeptide donors, peptidoglycan cross-linking 
in these mutants requires an L,D-transpeptidase 
(Ldtfm) that cleaves the L-Lys3-D-Ala4 peptide 
bond of the donor and links the carboxyl of L-
Lys3 to the side chain amine of the acceptor (Fig. 
1B). This mode of peptidoglycan cross-linking 
has been originally identified as a by-pass of the 
PBPs that confers high-level β-lactam resistance 
(10).  
Variation at the third position of the peptide 
stem concerns both the nature of the diamino 
acid present at this position, e.g. L-Lys or meso-
diaminopimelic acid (mesoDAP), and the 
presence or absence of a side chain comprising 
from one to five amino acids (5) (Fig. 1A). 
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Glycine and L-amino acids are incorporated into 
the side chain of peptidoglycan precursors by 
transferases of the Fem family that use 
aminoacyl-tRNAs as the substrate (11). D-
aspartic acid is activated as β-aspartyl-phosphate 
and ligated to the precursors by ATP-dependent 
ligases belonging to the ATP-Grasp superfamily 
(12). Synthesis of complete side chains is 
essential for β-lactam resistance mediated by 
low-affinity PBPs in Gram-positive bacteria, in 
particular methicillin resistance mediated by 
PBP2a in Staphylococcus aureus (13,14) and 
penicillin resistance mediated PBP2X in 
Streptococcus pneumoniae (15). For this reason, 
Fem transferases are considered as attractive 
targets for the development of novel antibiotics 
active against β-lactam-resistant pathogens 
(16,17). The antibacterial activity of such Fem 
inhibitors will ultimately depend upon the 
incapacity of cross-linking enzymes to use 
precursors with incomplete side chains.  
Interaction of the peptidoglycan cross-
linking enzymes with their substrates has not 
been extensively investigated, despite its pivotal 
role for drug development and for our 
understanding of the mechanisms of resistance to 
glycopeptides and β-lactams. In this report, the 
specificity of Ldtfm and of the PBPs was 
compared based on heterospecific expression of 
a Fem transferase of E. faecalis in E. faecium 
and search for modified stem peptides containing 
L-Lys3-L-Ala instead of L-Lys3-D-iAsn in the 
donor and acceptor positions of dimers generated 
in vivo by L,D-transpeptidation and  D,D-
transpeptidation. The specificity of Ldtfm was 
also studied in vitro by directly testing the cross-
linking of peptidoglycan fragments isolated from 
three bacterial species (E. faecium, Bacillus 
subtilis, and E. faecalis) representative of the 
structural variability at the third position of the 
stem peptides (Fig. 1A). Finally, Ldtfm 
homologues (Fig. 1C) were purified from E. 
faecalis and B. subtilis to compare the specificity 
of enzymes from bacteria producing 
peptidoglycan of different chemotypes. This 
analysis represents the first direct assessment of 
the specificity of peptidoglycan cross-linking 
enzymes since the PBPs are generally inactive in 
vitro. In addition, characterization of Ldtfs 
revealed that members of the L,D-transpeptidase 
family can also display L,D-carboxypeptidase 
and L,D-endopeptidase activities.  
 
EXPERIMENTAL PROCEDURES 
Production and Purification of L,D-
transpeptidases–A catalytically active fragment 
of Ldtfm from E. faecium M512 (residues 119 to 
466) was produced in E. coli and purified by 
affinity, anion exchange, and size exclusion 
chromatographies, as previously described (18).  
A fragment of the open reading frame 
encoding residues 136 to 474 of the L,D-
transpeptidase of E. faecalis strain JH2-2 (19), 
Ldtfs, was amplified with primers 5’-
AACCATGGGGAGTATCCGTCGAGGCAAT
GG-3’ and 5’-
AAGGATCCTACTTCTTCGCCGTAATCTA-
3’. The PCR product was digested with NcoI and 
BamHI (underlined) and cloned into pET2818, a 
derivative of pET2816 (18) lacking the sequence 
specifying the thrombin cleavage site. The 
resulting plasmid, pET2818Ωldtfs, was 
introduced in E. coli BL21(DE3) harboring 
pREP4GroESL (20) and bacteria were grown at 
37°C to an optical density at 600 nm of 0.8 in 
brain heart infusion broth (Difco, Elancourt, 
France) containing ampicillin (100 µg/ml). 
Isopropyl-β-D-thiogalactopyranoside was added 
to a final concentration of 0.5 mM and 
incubation was continued for 17 hours at 16°C. 
The cells were disrupted by sonication in 50 mM 
Tris-HCl pH 7.5 containing 300 mM NaCl and 
cell debris were removed by centrifugation. Ldtfs 
was purified from the resulting clarified lysate 
by affinity chromatography on Ni2+-
nitrilotriacetate-agarose resin (Qiagen GmbH, 
Hilden, Germany). Proteins eluted with 200 mM 
imidazole were dialyzed against 50 mM Tris-
HCl (pH 8.0) containing 60 mM NaCl, loaded 
onto an anion exchange column (MonoQ HR5/5, 
Amersham Biosciences, Saclay, France) 
equilibrated with the same buffer. Ldtfs, eluting 
at approximately 300 mM NaCl, was further 
purified by size exclusion chromatography on a 
Superdex HR10/30 column (Amersham 
Biosciences) equilibrated with 50 mM Tris-HCl 
(pH 7.5) containing 300 mM NaCl. The protein 
was obtained with an overall yield of 3 mg per 
liter of culture, as estimated by the BioRad 
Protein Assay using bovine serum albumin as a 
standard. The protein was stored at -80°C in 50 
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mM Tris-HCl (pH 7.5) containing 300 mM 
NaCl. 
The open reading frame encoding the L,D-
transpeptidase of B. subtilis strain 168, LdtBs, 
previously named ykuD (21), was amplified with 
primers 5’-
AACCATGGGGCTGCTTACGTACCAGGTG
AAGC-3’ and 5’-
TTGGATCCCCGGTTAATCGTGACTCTCGT-
3’. The PCR product digested with NcoI and 
BamHI (underlined) was cloned into pET2818 
and LdtBs was produced in E. coli 
BL21(DE3)/pREP4GroESL using the inducing 
conditions described above for the L,D-
transpeptidase of E. faecalis. LdtBs was purified 
in one step by affinity chromatography on Ni2+-
nitrilotriacetate-agarose resin (Qiagen), dialyzed 
against 50 mM Tris-HCl (pH 7.5) containing 100 
mM NaCl, and stored at -20° C in the same 
buffer. Ten mg of protein were obtained per liter 
of culture.  
L,D-transpeptidase assays–The source of 
the disaccharide-peptides used as substrates was 
as follows. The disaccharide-tetrapeptide 
substituted by a D-iso-asparagin residue (L-Lys3-
D-iAsn) was purified from the peptidoglycan of 
E. gallinarum strain SC1 (22). The disaccharide-
pentapeptide and the disaccharide-tetrapeptide 
substituted by an L-Ala-L-Ala side chain (L-Lys3-
L-Ala-L-Ala) were purified from E. faecalis JH2-
2 (19) and from a derivative of strain JH2-2 
harboring the vanA glycopeptide resistance gene 
cluster (23), respectively. The disaccharide-
tetrapeptide containing meso-diaminopimelic 
acid (mesoDAP3) was purified from E. coli strain 
ATCC 25113. The procedures used for 
peptidoglycan preparation, digestion with 
muramidases, and reduction of MurNAc to 
muramitol with sodium borohydride have been 
previously described for enterococci (24) and E. 
coli (25). The resulting muropeptides were 
separated by rp-HPLC in acetonitrile gradients 
containing trifluoroacetic acid (24) and identified 
by mass spectrometry (MS). The concentration 
of the muropeptides was estimated by amino 
acid analysis after acidic hydrolysis with a 
Hitachi autoanalyser (26).   
In vitro formation of muropeptide dimers 
was tested in 10 µL of phosphate buffer (20 mM, 
pH 7.0) containing the L,D-transpeptidase (7 
µM) from E. faecium (Ldtfm), E. faecalis (Ldtfs), 
or B. subtilis (LdtBs) and a combination of three 
reduced disaccharide-tetrapeptides (200 µM 
each) containing L-Lys3-D-iAsn, L-Lys3-L-Ala-L-
Ala or mesoDAP3 at the third position of a 
tetrapeptide stem. The reaction was incubated for 
2 hours at 37°C, desalted using a micro column 
(ZipTipC18, Millipore, Saint Quentin-en-
Yvelines, France), and analyzed by 
nanoelectrospray MS in the positive mode (Qstar 
Pulsar I, Applied Biosystem, Courtaboeuf, 
France). The sequence of the cross-links in 
dimers generated in vitro was determined by 
tandem mass spectrometry (MS/MS). Briefly, 
dimers were generated in vitro as described 
above except that the disaccharide-peptides used 
as substrates were not reduced. The reaction 
mixture was treated with ammonium hydroxide, 
desalted using a micro column (ZipTipC18, 
Millipore), and the resulting lactoyl-peptides 
were analyzed by nanoelectrospray MS/MS 
using N2 as the collision gas (24).  
The L,D-transpeptidase activity of Ldtfs was 
also tested by using the dipeptides L-Ala-L-Ala 
and D-Ala-D-Ala as acyl acceptors. The assay 
performed in 10 µl of 20 mM potassium 
phosphate buffer (pH 7.0) contained Ldtfs (7 
µM), the cognate disaccharide-tetrapeptide 
containing an L-Ala-L-Ala side chain as the acyl 
donor (200 µM), and 1 mM of L-Ala-L-Ala or D-
Ala-D-Ala (Sigma). The products of the 
reactions were identified by MS and MS/MS, as 
previously described (18).  
Expression of the bppA1 Gene of E. faecalis 
in E. faecium M512 and Analysis of 
Peptidoglycan Structure–The bppA1 gene of 
plasmid pDA15 (27) was subcloned under the 
control of the inducible promoter of pJEH4 (12) 
using XbaI and KpnI. The resulting plasmid, 
pJEH6(bppA1), was introduced by 
electroporation into E. faecium M512 (10). The 
recombinant strain was grown in brain heart 
infusion broth or agar (Difco) containing 
spectinomycin (120 µg/ml) to counter select loss 
of pJEH6(bppA1). Induction of the bppA1 gene 
was performed with 0.3 mM isopropyl-β-D-
thiogalactopyranoside at an optical density at 
600 nm of 0.02. Incubation was continued at 
37°C until the optical density reached 0.6 and 
bacteria were collected by centrifugation. 
Peptidoglycan was extracted with boiling SDS 
and digested with mutanolysin and lysozyme 
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(Sigma-Aldrich) (24). The resulting 
muropeptides were cleaved under alkaline 
conditions to generate lactoyl-peptides, separated 
by rp-HPLC, and analyzed by MS and MS/MS 
(24).  
 
RESULTS AND DISCUSSION 
Probing the Substrate Specificity of Ldtfm in 
Vivo–Synthesis of the side chain of 
peptidoglycan precursors is catalyzed in E. 
faecalis by two members of the Fem family, 
BppA1 and BppA2, that sequentially add two L-
Ala residues (Fig. 1A) (23). In E. faecium, D-Asp 
is added to the precursors by the Aslfm ligase and 
subsequently partially amidated (12). The bppA1 
gene of E. faecalis was cloned under the control 
of an inducible promoter to generate plasmid 
pJEH6 and introduced into E. faecium M512 in 
order to manipulate the structure of the substrate 
of the cross-linking reaction which can be 
catalyzed in this mutant by Ldtfm and by the 
PBPs (28). The BppA1 transferase efficiently 
competed with the Aslfm ligase in E. faecium 
M512/pJEH6(bppA1) since the main monomers 
contained L-Ala instead of D-iAsp (peaks 1 and 2 
in Fig. 2). The free side chains in the major 
dimers generated by L,D- and D,D-
transpeptidation also contained L-Ala indicating 
that Ldtfm, as the PBPs, had catalyzed cross-link 
formation using donors containing this residue 
(Peaks 3, 4, and 5 in Fig. 2). The cross-links of 
dimers generated by L,D-transpeptidation 
exclusively contained D-iAsp whereas D-iAsp or 
L-Ala was found in cross-links generated by D,D-
transpeptidation. Thus, Ldtfm tolerated the 
substitution only in the donor substrate in 
contrast to the PBPs that catalyzed 
peptidoglycan cross-linking with modified donor 
and acceptor substrates. Modifications of the 
side chain of peptidoglycan precursors were also 
shown to be tolerated by PBPs of E. faecalis and 
S. aureus in previous studies (12,24).  
Ldtfm Is Also Specific for D-iAsn-substituted 
Acceptors in Vitro–The specificity of Ldtfm was 
analyzed by incubating the enzyme with three 
disaccharide-tetrapeptides obtained by digestion 
of peptidoglycan of three different chemotypes 
with muramidases. The substrates were 
representative of the main variations found at the 
third position of peptidoglycan precursors of 
Gram-positive bacteria including the absence of 
a side chain (mesoDAP3 in B. subtilis) and 
presence of a side chain consisting of D and L 
amino acids (L-Lys3-D-iAsn in E. faecium and L-
Lys3-L-Ala-L-Ala in E. faecalis) (Fig. 1A). With 
these three substrates, the cross-linking reaction 
can potentially lead to the formation of nine 
dimers including three homodimers, if the same 
disaccharide-peptide is used as the donor and the 
acceptor substrate, and six heterodimers, if 
different disaccharide-peptides are used in all 
possible combinations (Table 1). Mass 
spectrometry analyses of the reaction products 
indicated that Ldtfm catalyzed formation of a 
homodimer containing D-iAsn-substituted 
acceptor and donor stem peptides and of a 
heterodimer containing stem peptides substituted 
by L-Ala-L-Ala and D-iAsn (Fig. 3). Tandem 
mass spectrometry was performed to determine 
whether the L-Ala-L-Ala-substituted 
disaccharide-peptide had been used as a donor or 
an acceptor substrate in the formation of the 
heterodimer (Fig. 4). Fragmentation was 
performed on lactoyl-peptides obtained by 
cleavage of the disaccharide-peptides by alkaline 
treatment since amino acid sequencing of 
peptidoglycan dimers is more efficient in the 
absence of the disaccharide moiety of the 
molecules (24). This treatment also converts D-
iAsn into D-iAsp (24). As detailed in Fig. 4, 
fragmentation of the heterodimer allowed 
assigning L-Ala-L-Ala to the free side chain of 
the donor stem and D-iAsp to the cross-link. 
Thus, Ldtfm tolerated presence of L-Ala in the 
donor but not in the acceptor substrate of the 
cross-linking reaction. The specificity of Ldtfm 
observed in vitro in the absence of any other cell 
wall biosynthesis enzymes accounts for the in 
vivo selection of the acceptor and donor 
substrates in the derivative E. faecium M512 
producing the BppA1 transferase (above).    
Of note, interaction of the D,D-
transpeptidases (PBPs) with their donor and 
acceptor substrate has not been extensively 
investigated with purified PBPs, since the 
enzymes are generally inactive in vitro (29), 
except in very special cases involving highly 
reactive substrates (e.g. thioester; ref. (30)) and 
atypical enzymes (e.g. the soluble R61 D,D-
peptidase from Streptomyces spp. ref. (31,32)). 
Recently, a peptidoglycan polymerization assay 
has been developed for the purified PBP1a and 
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1b of E. coli as these bi-functional enzymes 
catalyze transglycosylation and transpeptidation 
of the natural substrate, a dissacharide-peptide 
linked to undecaprenyl lipid carrier by a 
phosphodiester bond (lipid II) (33,34). This 
approach has not been yet developed for the 
PBPs of Gram-positive bacteria that use even 
more complex precursors due to the presence of 
an additional side chain. Thus, characterization 
of Ldtfm in the current study represents the first 
direct in vitro assessment of the substrate 
specificity of peptidoglycan cross-linking 
enzyme. 
The Ldtfm Homologue from B. subtilis Is 
Specific for mesoDAP-Containing Acceptors but 
Functions with Various Donors–Having shown 
that Ldtfm is specific for its cognate acceptor both 
in vivo and in vitro, our following aim has been 
to determine whether Ldtfm homologues from 
bacteria producing peptidoglycan of different 
chemotypes are also specific for their respective 
acceptor. We have started this analysis with the 
homologue from B. subtilis, LdtBs, because the 
crystal structure of this protein has been recently 
solved in the framework of a structural genomics 
project that did not include functional 
investigations (21). The full length LdtBs (167 
residues) contains a putative peptidoglycan-
binding N-terminal domain consisting of a single 
LysM module (residues 5-49, Pfam PF01476) 
and a C-terminal domain that can be 
superimposed to the catalytic domain of Ldtfm 
with a root mean square deviation of 1.21Å for 
the 103 Cα atoms in common (35). The purified 
protein produced in E. coli catalyzed formation 
of homodimers from disaccharide-tetrapeptides 
containing mesoDAP at the third position of the 
stem peptides (Fig. 5A). Thus, Ldtfm and LdtBs 
displayed both L,D-transpeptidase activity on 
muropeptides despite limited sequence identity 
(23 % for the catalytic domain) and different 
domain compositions (Fig. 1C). LdtBs also 
catalyzed formation of heterodimers containing 
mesoDAP3 in one stem and L-Lys3-D-iAsn or L-
Lys3-L-Ala-L-Ala in the other stem (Fig. 5A). 
Tandem mass spectrometry indicated that stems 
containing L-Lys3-D-iAsn and L-Lys3-L-Ala-L-
Ala were present in the donor position of the 
dimers (Fig. 5B). Thus, LdtBs was specific for its 
cognate mesoDAP-containing acceptor but 
tolerated variations in the structure of the donor 
substrate. 
Ldtfs from E. faecalis Is Specific for 
Disaccharide-Peptides Containing an L-Ala-L-
Ala Side Chain in both the Acceptor and Donor 
Substrates–The chromosome of E. faecalis 
encodes a protein of 474 residues, designated 
Ldtfs, which is closely related to Ldtfm (37% 
identity for the catalytic domain). The two 
proteins display the same domain composition 
with an overall sequence identity of 29% (Fig. 
1C). Ldtfs catalyzed formation of homodimers 
from the cognate branched disaccharide-
tetrapeptide containing L-Lys3-L-Ala-L-Ala 
(observed monoisotopic mass of 1,987.96, see 
Table 1 for the calculated mass). Muropeptides 
containing mesoDAP3 or L-Lys3-D-iAsn were not 
used for dimer formation indicating that Ldtfs is 
specific for the L-Ala-L-Ala side chain both in 
the donor and acceptor positions.  
Ldtfs Displays L,D-Carboxypeptidase 
Activity–MS analysis of the product of the L,D-
transpeptidation reaction catalyzed by Ldtfs 
revealed the presence of an additional product 
(observed monoisotopic mass of 1,916.81) 
differing from the expected dimer (1987,97; 
above) by the loss of one alanyl residue (Fig. 
6A). Tandem mass spectrometry indicated that 
this additional product was a dimer generated by 
L,D-transpeptidation which lacked D-Ala4 in the 
acceptor stem (data not shown). The L,D-
carboxypeptidase activity of Ldtfs could have 
cleaved the L-Lys3-D-Ala4 peptide bond in the 
acceptor stem of the dimer. In addition or 
alternatively, Ldtfs could have cleaved the 
substrate prior to its utilisation as an acceptor in 
the cross-linking reaction since a monomer 
containing a tripeptide stem ending in L-Lys3 
was also detected in the reaction mixture. The 
latter observation indicated that the L,D-
transpeptidase and L,D-carboxypeptidase 
activities of Ldtfs acted in competition since 
tripeptide stems cannot be used as a donor 
substrate. In contrast, L,D-carboxypeptidase 
activity was not detected for Ldtfm from E. 
faecium (18) and LdtBs from B. subtilis (data not 
shown). L,D-carboxypeptidases specific for the 
L-Lys3-D-Ala4 or mesoDAP3-D-Ala4 bond of 
peptidoglycan precursors have been described in 
E. coli (36), Pseudomonas aeruginosa (37), and 
Lactococcus lactis (38). These enzymes are 
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unrelated to Ldtfm and were only shown to have a 
hydrolytic activity. 
Muropeptides Containing a Stem 
Pentapeptide are Substrate of Ldtfs–Replacement 
of the disaccharide-tetrapeptide substituted by L-
Ala-L-Ala by the corresponding pentapeptide in 
the cross-linking assay led to the formation of 
hydrolysis and transpeptidation products (Fig. 
6B). Ldtfs displayed endopeptidase activity since 
the enzyme cleaved the L-Lys3-D-Ala4 peptide 
bond of the pentapeptide generating a tripeptide 
and the dipeptide D-Ala-D-Ala. Ldtfs also formed 
dimers containing a tripeptide stem and a 
pentapeptide stem at the donor and acceptor 
position, respectively. Combination of the L,D-
transpeptidase and L,D-endopeptidase activity 
led to the formation of dimers containing two 
tripeptide stems. In contrast to Ldtfs, the L,D-
transpeptidase from E. faecium functions 
exclusively with acyl donors containing a 
tetrapeptide stem  (18). 
Exchange Reactions Catalyzed by Ldtfs–The 
L,D-transpeptidase of E. faecium has been 
previously shown to cleave the L-Lys3-D-Ala4 
peptide bond of an acyl donor substrate and to 
form a peptide bond between the alpha carboxyl 
of L-Lys3 and free D-amino acids (18). 
Dipeptides were tested in a similar exchange 
reaction catalyzed by Ldtfs since this enzyme 
catalyzed formation of tripeptide and D-Ala-D-
Ala from pentapeptide (above). Ldtfs used the 
cognate disaccharide-tetrapeptide and D-Ala-D-
Ala as acyl donor and acceptor, respectively, 
leading to the formation of the corresponding 
pentapeptide (Fig. 6C). Strikingly, L-Ala-L-Ala 
was not used as an acyl acceptor although the 
dipeptide mimics the side chain of the acceptor 
of the cross-linking reaction. This observation 
strongly suggests that the dipeptide D-Ala-D-Ala 
and the L-Ala-L-Ala side chain of muropeptides 
occupy different subsites in the catalytic cavity 
of the enzyme. The dipeptide D-Ala-D-Ala may 
occupy the position of the leaving group of the 
donor substrate. This would account for the 
specificity of Ldtfs for D-Ala-D-Ala in the 
exchange reaction. A distinct subsite may 
accommodate the L-Ala-L-Ala side chain of the 
peptidoglycan precursors. Since the dipeptide L-
Ala-L-Ala was not a substrate of Ldtfs, 
recognition of the acceptor of the cross-linking 
reaction appears to involve a portion of the 
molecule larger than the L-Ala-L-Ala moiety of 
the molecule. The existence of two subsites in 
the catalytic cavity of the L,D-transpeptidases is 
supported by the structure of Ldtfm from E. 
faecium (35). The catalytic domain of this 
enzyme contains two access paths to the putative 
active cystein residue that could correspond to 
the binding sites of the acceptor and donor 
substrates (35).   
Conclusions–By-pass of the D,D-
transpeptidase activity of the PBPs by the L,D-
transpeptidase activity of Ldtfm confers high-
level cross-resistance to β-lactams and 
glycopeptides in E. faecium since these drugs do 
not interact with the enzyme and its substrate, 
respectively (9). Ldtfm is the first functionally 
characterized member of a novel family of 
cystein peptidases which are widespread both in 
Gram-positive and Gram-negative bacteria 
(18,35). We have characterized two additional 
members of the family from B. subtilis (LdtBs) 
and E. faecalis (Ldtfs) and shown that these 
enzymes catalyze the cross-linking of purified 
peptidoglycan fragments in vitro. Comparison of 
the specificity of Ldtfm, LdtBs, and Ldtfs (Table 2) 
indicated that diversification of the structure of 
peptidoglycan precursors associated with 
speciation had led to a parallel evolution of the 
substrate specificity of members of the Ldtfm 
protein family. This evolution concern mainly 
the acceptor since for this substrate all three L,D-
transpeptidases were specific for their cognate 
disaccharide-peptides. In contrast, Ldtfm and 
LdtBs tolerated substitutions at the third position 
of the donor. The specificity of the L,D-
transpeptidases for the acceptor stem indicates 
that blocking the assembly of the side chain of 
peptidoglycan precursors is a potential strategy 
to combat resistance involving L,D-
transpeptidases.   
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The authors thank L. Gutmann for helpful comments on the manuscript. The abbreviations used are: 
D-iAsn, D-iso-asparagine; D-iAsp, D-iso-aspartic acid; D-iAsx, D-iAsn or D-iAsp; GlcNAc, N-
acetylglucosamine; mesoDAP, meso-diaminopimelic acid; MS, mass spectrometry; MS/MS, tandem mass 
spectrometry; MurNAc, N-acetylmuramic acid; PBP, penicillin-binding protein; rp-HPLC, reverse-phase 
high-pressure liquid chromatography. 
 
 
FIGURE LEGENDS 
 
FIGURE 1. Diversity of the structure of peptidoglycan cross-links and their mode of synthesis in 
Gram-positive bacteria. (A) Structure of peptidoglycan subunits from E. faecium, E. faecalis, and B. 
subtilis. The disaccharide-peptide subunit contains β-1-4 linked N-acetyl-glucosamine (GlcNAc) and N-
acetyl-muramic acid (MurNAc). The D-lactoyl moiety of MurNAc is substituted by a stem pentapeptide 
containing L-Lys3 in E. faecium and E. faecalis or meso-diaminopimelic acid (mesoDAP3) in B. subtilis 
and E. coli. The side chain amino group of L-Lys3 is substituted by a D-iso-asparaginyl or D-iso-aspartyl 
residue (D-iAsx) in E. faecium and by L-Ala-L-Ala in E. faecalis. The amino group of the acyl acceptor 
participating in the formation of the cross-links is indicated by an arrow. (B) Schematic representation of 
muropeptide dimers generated by D,D- and L,D-transpeptidation. The acceptor stem in the represented 
dimers is a tripeptide ending in L-Lys3. Additional residues can be found at its position (D-Ala4, Gly4, D-
Ala4-D-Ala5) (9). (C) Domain composition of L,D-transpeptidases from E. faecium (Ldtfm), E. faecalis 
(Ldtfs), and B. subtilis (LdtBs). Hatched boxes represent hydrophobic regions that could act as membrane 
anchors in Ldtfm and Ldtfs (35). LdtBs comprises a LysM peptidoglycan-binding module linked to the 
catalytic domain (domain II) (21). For each L,D-transpeptidase, the portion of the proteins that has been 
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produced in E. coli is indicated by a thick line terminated by the sequence of the affinity tag (one letter 
code). 
 
FIGURE 2. Peptidoglycan composition of E. faecium M512 producing BppA1 from E. faecalis. (A) 
rp-HPLC profile of muropeptides from E. faecium M512/pJEH6(bppA1). Bacteria were grown in the 
presence of spectinomycin (120 µg/ml) to counter select loss of plasmid pJEH6(bppA1) and of isopropyl-
β-D-thiogalactopyranoside (0.3 mM) to induce the bppA1 gene encoding a transferase of the Fem family 
for incorporation of L-Ala into the side chain of peptidoglycan precursors. Peptidoglycan was extracted 
with SDS, treated with ammonium hydroxide, and the resulting lactoyl-peptides were separated by rp-
HPLC. mAU, absorbance unit x 103 at 210 nm. (B) Structure of muropeptides. The relative abundance (%) 
of the material in peaks 1 to 5 was calculated by integration of the absorbance at 210 nm. The retention 
time (RT) is indicated for minor muropeptides which could not be assigned to specific peaks due to their 
low abundance. The structure of lactoyl-peptides was deduced from the observed monoisotopic mass 
(Mass) and confirmed by tandem mass spectrometry for most monomers and dimers (indicated by a star). 
The observed and calculated mass differed at the maximum by 0.2. The stem peptide of monomers and the 
acceptor stem of dimers consisted of the tripeptide L-Ala1-D-iGln2-L-Lys3 (Tri), the tetrapeptide L-Ala1-D-
iGln2-L-Lys3-D-Ala4 (Tetra), and the pentapeptide L-Ala1-D-iGln2-L-Lys3-D-Ala4-D-Ala5 (Penta). In certain 
muropeptides of low abundance, the C-terminal D-Ala4 was replaced by a glycyl residue (Gly C-ter). 
Cross-links generated by D,D-tanspeptidases (DD) contained D-iAsp or L-Ala (D-Ala4ÆD-iAsp-L-Lys3 and 
D-Ala4ÆL-Ala-L-Lys3). Cross-links generated by L,D-transpeptidation (LD) exclusively contained D-iAsp 
(L-Lys3ÆD-iAsp-L-Lys3).  
 
FIGURE 3. Analysis of the products of the cross-linking reaction catalyzed by Ldtfm in vitro. Three 
reduced disaccharide-tetrapeptides containing mesoDAP3, L-Lys3-D-iAsn, or L-Lys3-L-Ala-L-Ala were 
incubated with Ldtfm and the products of the cross-linking reaction were analyzed by nanoelectrospray 
mass spectrometry. Peaks at m/z 942.38, 1,011.41, and 1,039.46 were assigned to be the [M+H]+ ions of 
the substrates (reduced disaccharide-tetrapeptides containing mesoDAP3, L-Lys3-D-iAsn, or L-Lys3-L-Ala-
L-Ala, respectively). Peaks at m/z 966.93, 977.89, and 985.88 were assigned to be the [M+2H]2+, 
[M+H+Na]2+, and [M+H+K]2+ ions of the homodimer containing L-Lys3-D-iAsn in the donor and acceptor 
stems as the deduced monoisotopic mass (1,931.85) matched the calculated mass (1,931.91; Table 1). The 
monoisotopic mass of 1,959.82, deduced from peaks at m/z 980.93 [M+2H]2+, 991.91 [M+H+Na]2+, 
999.89 [M+H+K]2+, matched the calculated monoisotopic mass of a heterodimer containing L-Lys3-D-
iAsn and L-Lys3-L-Ala-L-Ala (1,959.94). Minor peaks at m/z 964.74 and 974.06 were assigned to be the 
[M+2H+K]3+ ions of trimers containing three L-Lys3-D-iAsn (calculated monoisotopic mass of 2,853.33) 
or two L-Lys3-D-iAsn and one L-Lys3-L-Ala-L-Ala (2,881.36), respectively.  
 
FIGURE 4. Structure of the heterodimer formed by Ldtfm. Fragmentation was performed on the ion at 
m/z 1,145.59 obtained by ammonium hydroxide treatment of the heterodimer with a monoisotopic mass of 
1,959.82 (Table 1). Boxes indicate ions generated by cleavage at single peptide bonds as indicated in the 
structure of the dimer. Ions at m/z 604.23 and 1,003.51 labelled with arrows establish that D-iAsp is 
present in the cross-link whereas L-Ala-L-Ala is located in the free side chain of the donor stem. The other 
peaks could correspond to additional loss of NH3 and CO plus NH3 and to combinations of fragmentations 
at two peptide bonds, as previously described (24). D-Lac, D-lactoyl. 
 
FIGURE 5. Analysis of the dimers formed by LdtBs. (A) MS analysis of the products of the cross-linking 
reaction catalyzed by LdtBs. Three reduced disaccharide-tetrapeptides containing mesoDAP3, L-Lys3-D-
iAsn, or L-Lys3-L-Ala-L-Ala were incubated with LdtBs and the products of the reaction were analyzed by 
nanoelectrospray MS. Peaks at m/z 942.41, 964.39, and 980.36 were assigned to be the [M+H]+, [M+Na]+, 
and [M+K]+ ions of the substrate containing mesoDAP3, respectively. Peaks at m/z 897.92, 908.90, 
916.89, 919.88, 927.88, and 935.86 were assigned to be the [M+H+H]2+, [M+H+Na]2+, [M+H+K]2+, 
[M+Na+Na]2+, [M+Na+K]2+, and [M+K+K]2+ ions of the homodimer containing mesoDAP3 in the donor 
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and acceptor stems (calculated monoisotopic mass of 1,793.77; Table 1). The monoisotopic mass of 
1,862.68 deduced from peaks at m/z 932.44 [M+2H]2+, 943.43 [M+H+Na]2+, 951.42 [M+H+K]2+, 954.43 
[M+Na+Na]2+, and 962.41 [M+Na+K]2+ matched the calculated monoisotopic mass of a heterodimer 
containing mesoDAP3 and L-Lys3-D-iAsn (1,862.84). The monoisotopic mass of 1,890.67 deduced from 
peaks at m/z 946.45 [M+2H]2+, 957.45 [M+H+Na]2+, and 965.43 [M+H+K]2+ matched the calculated 
monoisotopic mass of a heterodimer containing mesoDAP3 and L-Lys3-L-Ala-L-Ala (1,890.87). (B) 
Fragmentation of dimers obtained by ammonium hydroxide treatment. The peaks generated by the 
cleavage of a single peptide bond are boxed. Arrows indicate peaks used to assign stem peptides to the 
acceptor and donor positions of heterodimers.  
 
FIGURE 6. Diversity of the reactions catalyzed by Ldtfs in vitro. (A) Products generated from a 
disaccharide-tetrapeptide by the L,D-carboxypeptidase and the L,D-transpeptidase activities of Ldtfs alone 
or in combination. (B) Products generated from a disaccharide-pentapeptide by the L,D-endopeptidase and 
L,D-transpeptidase activities of Ldtfs. (C) Use of the dipeptide D-Ala-D-Ala as an acyl acceptor to form a 
pentapeptide from a tetrapeptide. 
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TABLE 1. Calculated monoisotopic mass of the dimers generated by L,D-transpeptidation. Cross-
linking of three reduced disaccharide-tetrapeptides containing L-Lys3-D-iAsn, mesoDAP3, and L-Lys3-L-
Ala-L-Ala in all possible combinations can lead to a total of nine dimers including three homodimers and 
six heterodimers. The calculated monoisotopic mass of the corresponding lactoyl-peptides is indicated in 
parenthesis. Disaccharide-peptides and lactoyl-peptides contain D-iAsn and D-iAsp, respectively. 
 
Third position of the tetrapeptide donor stem (X3-side chain) Third position of the 
tripeptide donor stem 
(X3-side chain) L-Lys3-D-iAsx mesoDAP3 L-Lys3-L-Ala- L-Ala 
L-Lys3-D-iAsx 1,931.91 
(1,117.53) 
1,862.84 
(1,047.47) 
1,959.94 
(1,144.57) 
 
mesoDAP3 
 
1,862.84 
(1,047.47) 
 
1,793.77 
(977.42) 
 
1,890.87 
(1,074.52) 
 
L-Lys3-L-Ala- L-Ala 
 
1,959.94 
(1,144.57) 
 
1,890.87 
(1,074.52) 
 
1,987.97 
(1,171.62) 
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TABLE 2. Muropeptides used as acceptor and donor substrates by the L,D-
transpeptidases from E. faecium (Ldtfm), E. faecalis (Ldtfs) and B. subtilis 
(LdtBs). The substrates were disaccharide-tetrapeptides differing at the third 
position as indicated (X3-side chain).  
 
L,D-transpeptidase Acceptor    Donor 
Ldtfm L-Lys3-D-iAsn                   L-Lys3-D-iAsn 
L-Lys3-L-Ala-L-Ala 
LdtBs 
 
mesoDAP3 
 
mesoDAP3 
L-Lys3-D-iAsn 
L-Lys3-L-Ala-L-Ala 
Ldtfs L-Lys3-L-Ala-L-Ala           L-Lys3-L-Ala-L-Ala 
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Major monomers (57.8%) 
Peak   % Mass Stem Side chain 
1 32.5 488.2* Tri L-Ala 
2 25.3 559.3* Tetra L-Ala 
Minor monomers 
Mass RT Stem Side chain 
417.2* 30.2 Tri none 
474.2* 32.5 Tetra (Gly C-ter) none 
488.3* 39.0 Tetra none 
532.2* 42.0 Tri D-iAsp 
 603.3 43.0 Tetra D-iAsp 
545.3* 45.6 Tetra (Gly C-ter) L-Ala 
630.3* 54.6 Penta L-Ala 
Major Dimers (42.2%) 
Peak % Mass Acceptor 
Stem 
Cross-link Side chain 
3 11.9 1,073.5* 
1,073.5* 
Tri 
Tetra DD     D-iAsp 
LD      D-iAsp 
L-Ala 
L-Ala 
4 11.7 1,029.5* 
1,144.6* 
Tri 
Tetra 
DD     L-Ala 
DD     D-iAsp 
L-Ala 
L-Ala 
5 18.6 1,100.6* Tetra DD     L-Ala L-Ala 
Minor Dimers 
Mass RT Acceptor Stem Cross-link Side chain 
 1,117.5 
1,059.5* 
63.7 
63.7 
Tetra 
Tetra (Gly C-ter) 
LD     D-iAsp   
LD     D-iAsp   
D-iAsp 
L-Ala 
1,002.5* 64.6 Tri LD     D-iAsp   L-Ala 
1,130.6* 66.0 Tetra (Gly C-ter) DD     D-iAsp   L-Ala 
A 
30.0 40.0 50.0 60.0 70.0 80.0 90.0 min 
1 2 
3
1000 
 800 
 600 
 400 
mAU 
 200 
   0 
4 5
B 
Fig. 2 
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